-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$3.75326.14% Upside
Gossamer Bio, Inc. Frequently Asked Questions
-
What analysts cover Gossamer Bio, Inc.?
Gossamer Bio, Inc. has been rated by research analysts at H.C. Wainwright, Barclays, Raymond James, SMBC Nikko in the past 90 days.